Back to VCNXView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
View Full LandscapeDrug Information
Target Indication
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Clinical Trial
NCT04815720Last updated: 12/4/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
2 doses of vaccine Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)Phase 3
Human Papillomavirus (HPV) Infection
11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha)Phase 3
HPV InfectioN
Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)Phase 3
Norovirus Infections
PepinemabPhase 2
Alzheimer Disease
Avelumab and PepinemabPhase 2
Metastatic Pancreatic Adenocarcinoma
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts